Role of collagenous matrices in the adhesion and growth of cells by unknown
Role of Collagenous Matrices
in the Adhesion and Growth of Cells
It has long been appreciated that, for many types of cells,
attachment to a substrate is required for their replication.
Collagen substrates enhance the growth (64, 70, 109, 238) as
well as the differentiation (40, 69, 85, 86, 146, 161, 184), of
many cells in culture above that observed with other substrates
such as plastic and glass. As discussed in this report, many
cultured cells including fibroblasts, myoblasts, hepatocytes,
chondrocytes, and certain epithelial cells are thought not to
bind directly to the collagen substrate or to the plastic surface
of culture dishes (31, 73, 74, 76, 77, 89, 93, 113, 164, 220).
Instead, extracellular glycoproteins bind the cells to the sub-
strate. One of these attachment proteins, fibronectin, has been
extensively studied (99, 151, 166, 227, 228, 244). Fibronectin is
produced by fibroblasts (13, 197, 246) and endothelial cells
(102, 140) as well as some other cell types. It is also present in
high concentrations in blood and serum (152). In culture,
serum fibronectin, as well as that produced by the cells, can
bind to both the collagen substrates and the tissue culture
plastic surface and mediate the attachment of cells (73, 113,
164, 242). Circulating fibronectin participates in a variety of
reactions important to wound healing, including the adhesion
and spreading of platelets on collagen (10, 14, 75, 100, 204),
binding to the fibrin clot (74, 150, 198) and to collagen (37, 46,
94, 103, 119), promoting opsonization reactions by phagocytic
cells (18, 94, 201), and promoting fibroblast migration (6, 61).
Thus, fibronectin not only functions as an attachment protein,
but also may play an important role in repair reactions.
In the case of certain differentiated cells, such as chondro-
cytes (89) and epithelial cells (159, 220), glycoproteins different
from fibronectin are active in attachment. The components of
these extracellular matrices of fibroblasts, chondrocytes, and
epithelial cells differ with the cell type, and they require
separate attachment proteins to provide additional specificity
to the interaction ofthe cell with its matrix. Alterations in cell-
substratum interactions are observed in differentiating cells
and after spontaneous transformation of cells or exposure to
oncogenic agents (99, 228). This review will briefly outline our
current knowledge of the types of collagen and their distribu-
tion and biosynthesis. Then, the interaction of cells with col-
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lagen and other matrix components will be described, with
emphasis on cell adhesion, differentiation, and growth.
COLLAGEN
Structure, Biosynthesis, and Degradation
Numerous criteria define a collagen and distinguish it from
other proteins (22, 49, 50, 58, 141, 148, 184). Collagens contain
a triple-helical segment composed of three chains that have a
characteristic composition including 33% glycine, ^-10% pro-
line, 10% hydroxyproline, and variable amounts of hydroxy-
lysine. Collagens, but not other proteins, are degraded by
bacterialcollagenases, which recognize and cleave the sequence
1
gly-X-pro-gly. These, as well as other features such as their x-
ray pattern, establish certain structural proteins as collagens
and other proteins as containing collagenous domains. At
present, two nonstructural proteins having collagenous seg-
ments have been identified: Clq, a component of the comple-
ment cascade (188), and acetylcholinesterase (192). Detailed
molecular models for these molecules have been proposed.
At least five isotypes of collagen molecules have been char-
acterized, and others probably exist (Table I) (22). Although
the interstitial collagens, types I, II, and III, are the products of
separate genes and have unique amino-acid sequences, in other
respects they are quite similar. Each molecule contains a triple-
helical domain, roughly 300 x 1 .5 nm, composed of three
chains, each 94,500 daltons. Type I collagen, found in skin,
bone, and tendon, has two al(l)-chains and one a2(l)-chain.
In addition, collagen molecules containing only al(l)-chains
with the composition [al(1)13 have been identified and are
usually referred to as type I trimer (142, 157). Type I trimer is
found in tissues (105), as products ofcertain cultured cells (16,
33, 142, 144), and in tumors (149). Type II collagen is found
mainly in cartilage and contains three al(II)-chains (148). Type
III collagen, at one time thought to be "fetal" collagen, is
composed of three al(III)-chains and is most prominent in
blood vessels, skin, and the parenchyma of internal organs
(63). Many investigators consider it to be the reticulin described
by histochemical methods, although this has not been proved.
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TABLE I
The Collagen Isotypes
Types IV and V collagens have been described and partially
characterized. Type IV collagen is found in basement mem-
branes (22, 110) and probably contains two distinct chains that
are larger than the chains of other collagens (222). In addition,
type IV collagen has more carbohydrate, 3-hydroxyproline,
and hydroxylysine than the other collagens. Type V collagen,
which is present in skin, smooth muscle, placenta, and bone
(24, 32, 143, 190), contains two types of chains designated aA
and aB, or in the new terminology a2(V) and al(V), respec-
tively. Recent studies indicate that the two chains occur in the
same molecule in type V collagen from placenta (15), and
molecules containing only aB chains have been isolated from
cartilage (190).
The amino-acid sequences of the al(l)- and al(Il)-chains
have been determined, and partial sequences of the al(III)-
and a2(I)-chains are known (51). For each chain there is
considerable interspecies sequence homology (23).
The steps in the biosynthesis of collagen types I, II, and III
have been described (for reviews, see references 50, 141, 183).
These collagens are formed from procollagen, a larger, more
soluble precursor containing pro-a-chains (Fig. 1). The pro-
a1(I)-chain of type I collagen contains a central collagenous
region plus additional peptide sequences of - 13,000 daltons at
its amino-terminus and of 36,000 daltons at its carboxy-termi-
nus. Pro-a2(l)-, pro-a1(II)-, and pro-a l(III)-chains contain
analogous peptides, which are chemically distinct.
The chains are modified enzymatically after synthesis (Fig.
1) (183). These modifications include the introduction of hy-
droxyl groups into certain prolyl residues to form 3- and 4-
hydroxyproline and the hydroxylation and glycosylation of
some lysyl residues. Most prolyl residues that precede glycyl
residues in the molecule are hydroxylated in the 4-position of
the ring by an intracellular, probably membrane-bound en-
zyme, prolyl hydroxylase, which requires for activity ferrous
ion, ascorbic acid, a-ketoglutarate, and oxygen (223). Prolyl
residues hydroxylated in the 3-position have been found to
occur in the sequence 3-hydroxyproline-4-hydroxyproline-gly-
cine (1). Both proline and 4-hydroxyproline stabilize the col-
lagen helix (23, 184), whereas the role of 3-hydroxyproline
residues is unknown. Hydroxylation oflysyl residues is carried
out by a separate enzyme that has the same cofactor require-
ments as prolyl hydroxylase (147). In addition, some hydrox-
ylysyl residues are glycosylated by unique sugar transferases to
form galactosyl-hydroxylysine and glucosyl-galactosyl-hydrox-
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Synthesis and maturation of collagen. Certain prolyl and
lysyl residues on the nascent chains are hydroxylated by specific
enzymes. Although the hydroxylation begins on the nascent chains,
it can continue after completion and release of the chains, until the
triple helix forms. Helix formation also terminates glycosylation of
hydroxylysyl residues. The procollagen molecule is then secreted
from the cell where extracellular or membrane-bound enzymes
remove the noncollagenous extension peptides. The collagen mol-
ecules are enzymatically cross-linked to form stable fibers.
ylysine (58, 183). The function of the sugar residues is not
known.
Glycosylation and hydroxylation reactions occur in the pro-
a-chains and terminate when the chains assume a helical
configuration (183). To form type I procollagen, two pro-al(I)-
chains and one pro-a2(I)-chain associate, form disulfide bonds
at the carboxy-terminus, and coil into a triple helical protein
(50). Separate enzymes, procollagen N-protease and procolla-
gen C-protease, remove the amino-terminal and carboxy-ter-
minal peptides, respectively (50, 128, 183). Kinetic studies
indicate that the amino-terminal peptides are removed en bloc
either inside the cell or at the cell surface, whereas the carboxy-
terminal peptides are removed later (50). The liberated amino-
terminal peptides may regulate collagen synthesis by feedback
inhibition of translation (163, 239). Because collagen molecules
spontaneously aggregate into fibers, it is likely thatthe carboxy-
terminal peptides confer solubility on procollagen and that
procollagen C-protease may regulate fiber formation (21, 50).
Collagen molecules in fibrils are cross-linked via the conden-
sation ofaldehydes formed from certain lysyl and hydroxylysyl
residues in the molecule by the enzyme lysyl oxidase (49, 174,
175). Fibrillar type I collagen is readily identified in vivo at the
electron microscope level by its characteristic banding pattern
(80), whereas the appearance of the other collagens is either
Colla-
gen
type Composition Some distinguishing characteristics Tissue location
Cell types that synthesize various
collagen types
I [al (I)]2a2(I) Low carbohydrate, low hydroxylation of lysine Skin, bone, tendon, Fibroblasts, osteoblasts, smooth
cornea muscle cells, epithelium
II [a1(II)13 >10 hydroxylysines per chain Cartilage, cornea, vit- Chondrocytes, neural retinal cells,
reous body notochord cells
III [a1 (I II)]3 Contains cysteine, low hydroxylation of lysine Fetal skin, blood ves- Fibroblasts, myoblasts
sels, organs
IV [al(IV)13 Many lysines hydroxylated and glycosylated, Basement membrane Endothelial and epithelial cells
[a2(IV)]3 sugars other than glucose and galactose, low
alanine, high 3-hydroxyproline
V [al (V)]2a2(V) Elevated hydroxylysine, low alanine, contains Blood vessels, Smooth muscle cells, chondro-
(formerly 3-hydroxyproline smooth muscle cytes under certain conditions
aA-and aB-
chains)less distinct (type II), nonfibrillar (type IV), or unknown (types
III and V) (63).
Native collagen molecules and fibrous collagen are resistant
to most proteases and the initial step in their breakdown in
animals is carried out by a specific collagenase (80). Mamma-
lian collagenase cleaves at a single site approximately one-
fourth of the way from the carboxy-terminal end ofthe mole-
cule (82). The resulting fragments are much less stable than
the intact molecule and are presumed to denature and then be
degraded by other proteases. There is evidence to suggest that
there are collaggnasass specific for different collagen types. The
fibroblast collagenase cleaves collagen types I, II, and III,
whereas the neutrophil enzyme cleaves type I but not type III
collagen (95). In addition, certain tumor cells produce an
enzyme that cleaves type IV collagen (138) but not the others.
Synthesis of Collagen by Cultured Cells
With the exception of lymphocytes, reticulocytes, and other
blood-bome cells, most cells in culture synthesize collagen (68,
72, 127). Further, it has been shown that cultured cells can
accomplish all the reactions necessary to form and to cross-link
collagen fibers (134, 219). However, this is not an efficient
process and in culture up to 90% of the procollagen formed
accumulates in the medium (131). Much of the procollagen in
the medium lacks the amino-terminal peptides but maintains
the carboxy-terminal extensions (50). Presumably, the protease
that cleaves the carboxy-terminal portions is not sufficiently
active in most cells under culture conditions to achieve com-
plete conversion to collagen. Almost complete conversion,
however, has been noted with certain mouse fibroblast lines
(219).
The amount of collagen produced varies with the cell type.
Most fibroblast strains produce collagen as 5-10% of theirtotal
protein, whereas other cell types synthesize from 0.001 to 10%
of their total protein as collagen (68). Although cells freshly
removed from embryonic tendon synthesize collagen as 20-
50% ofthe totalprotein (36), once in culture, there is a decrease
to -3-5% of the total protein. Relatively minor modifications
of the culture medium (Table II), such as the addition of
sodium lactate and of ascorbic acid with lower serum levels,
allow the cells to maintain a high rate of collagen synthesis
(209). Ascorbic acid has long been recognized as essential for
the formation of normal connective tissue (26). Although the
translation of collagenous polypeptides is not affected in
ascorbic acid deficiency, hydroxyproline formation is reduced
(173), and the chains do not assume a helical configuration
Compounds
Inhibitors
cis-Hydroxyproline (50-200 tLg/ml) *
cis-4-Fluoro-L-proline
L-Azetidine-2-carboxylic acid
3,4-Dehydroproline
ß-Aminoproprionitrile (50 hg/ml)
a,a'-Dipyridyl (0.3 mM)
D-Penicillamine (1.0 mM)
Stimulators
Ascorbic acid (50ILg/ml)
Sodium lactate (40 mM)
Proline analogue
Enzyme cofactor
r
TABLE II
Compounds Specifically Affecting Collagen Synthesis and Maturation
Mechanism
Inhibits lysyl oxidase
Inhibits hydroxylases (iron chelator)
Binds to aldehydes
* Amount in parentheses denotes effective concentration for tissue culture studies.
$Numbers in parentheses are references.
(185). Addition of ascorbic acid has been reported to stimulate
proliferation of cells in culture (193), perhaps as a consequence
of the enhanced deposition of a collagenous matrix. It should
be noted that levels in most media are low and that ascorbic
acid has a short half-life (<12 h) in tissue culture (173).
Synthesis of Collagen by Differentiated Cells
Most fibroblasts produce both types I and III collagen
simultaneously (62). An even greater variety is observed with
smooth muscle cells that synthesize types I, III, IV, and V
collagens (143). Epithelial and endothelial cellssynthesize type
IV collagen, which is consistent with the role of these cells in
the formation of the basement membrane (for examples, see
references 8, 33, 96, 101, 202).
Freshly isolated chondrocytes synthesize type II collagen, a
cartilage-specific protein (224). With time in culture, the cells
become more fibroblastic and are found to synthesize type I
collagen or both types I and II (16, 231). Late cultures ofsuch
cells synthesize types I, II, III, and V, and type I trimer (16,
142). Factors involved in the loss of characteristic chondrocyte
activities during culture will be covered in the section Matrix
Proteins and Cell Differentiation.
Tissue levels of one or more of the collagens are altered in
a variety of diseases (21). In some cases, skin fibroblasts
cultured from such patients retain the collagen defect. For
example, tissue levels of type III collagen are reduced or absent
in patients with the Ehlers-Danlos type IV syndrome (179),
and the production of type III collagen by fibroblasts from the
skin of these patients is markedly reduced. Fibroblasts from
patients with some forms of osteogenesis imperfecta synthesize
an unusually high ratio of type III to type I collagen (171). In
addition, tumors often synthesize the collagen type character-
istic of their tissue of origin. For example, osteosarcomas
contain type I collagen (149), whereas chondrosarcomas con-
tain type II collagen (212). In general, the type and amount of
collagen synthesized by cellsin culture reflect their origins.
RECONSTITUTED COLLAGEN MATRICES
Preparation of Collagen Matrices
Collagen is often employed as a substrate for cultured cells
(40, 43-45, 64, 69, 85, 86, 109, 124, 125, 139, 146, 159, 205,
238). Such matrices can be prepared in a variety of forms
differing in their properties and components. In many cases,
an acid extract of rat tail tendon is dried on a culture dish.
Effect
Inhibits helix formation (4, 183, 194, 225)$
Inhibits collagen cross-linking (175)
Inhibits prolyl and lysyl hydroxylation (183)
Inhibits cross-linking (183)
Stimulates prolyl and lysyl hydroxylase (173)
Activates prolyl hydroxylase (223)
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but would also have other constituents. Commercial prepara-
tions of type I collagen have been used that may contain
substantial quantities of impurities including other proteins
and even glycogen. Some of the commercial preparations are
labeled types 1, 11, 111, IV, and V (Sigma Chemical Co., St.
Louis, Mo.). These designations refer to different purification
procedures, not to the genetically distinct collagens.
With purified collagens, weighed amounts are dissolved in
dilute acetic acid and this solution is placed on the surface of
plastic or glass culture dishes. The solvent is evaporated either
at room temperature or in a 37°C incubator. 10-50 tLg of
collagen are sufficient to cover the surface ofa 35-mm-diameter
dish (121). This substrate is probably not arranged as native-
type fibers and may even be denatured (78). A firm and
adherent gel can be generated from the acetic acid solution of
collagen by exposure to NH3 vapors (48). Again, the collagen
may not be present as native-type fibers.
Heat-reconstituted collagen gels are also used as substrates.
In this case, the collagen is dissolved in acetic acid and dialyzed
in the cold against 0.15 M NaCl buffered to pH 7.4 with
phosphate or Tris. The collagen remains in solution in the cold
overnight but forms a firm gel of native fibrils when warmed
(44, 81, 121). These gels can be used directly or can be liberated
from the surface of the dish to serve as a floating support (45,
205). Higher concentrations of collagen are used to prepare
heat-reconstituted substrates (1-4 mg/plate) than for the other
coatings and, for this reason, heat-reconstituted gels require
higher concentrations of attachment proteins or serum to sup-
port cell attachment (121). When nonphysiological levels of
phosphate buffer (>0.01 M) are used, calcium and other di-
valent cations are precipitated from the medium used for cell
attachment or culture. Cells attach to this precipitate but often
do not spread or divide (121).
Biological Effects
Erhmann and Gey in 1956 (48) were the first to systemati-
cally compare growth of many cell strains and tissue explants
on collagen substrates with growth on glass. They reported that
collagen gels in many cases improved cell growth. Subse-
quently, it has been observed that collagen substrates alter the
morphology (43, 235), migration (181), and adhesion (97, 113,
159) of cells and, in some cases, differentiation (124, 184). In
fact, it appears that, for certain cells, growth factors may not
be required if the cells are maintained on spec collagens
(203) or on the extracellular matrix laid down by the cells (70).
Fibroblasts require a collagen substrate for migration (181)
on the plastic filters used in the Boyden-chamber assay. Pre-
sumably, the fibroblasts must adhere to the filter in order to
move. In addition, collagen a-chains and small collagenous
peptides are reported to be chemotactic (180). Thus, collagen
and degradation products of collagen may be attractants for
fibroblasts in vivo during wound repair, fracture healing, and
embryogenesis.
COLLAGEN AND CELL ADHESION
Recent studies suggest that specific glycoproteins bind cells to
the substratum or to their collagenous matrix. There are a
variety of collagen isotypes, and specific binding proteins have
been described, while others probably exist. These proteins, of
which fibronectin is the best described, are matrix and cell
surface constituents. It has been demonstrated that certain cells
utilizing these glycoproteins can adhere to specific collagens
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(Table 11I). For example, whereas fibroblasts adhere well to all
collagens, chondrocytes bind preferentially to type 11 collagen
and epithelial and endothelial cells to type IV collagen. The
fibronectin-mediated attachment offibroblasts to collagen sub-
strates is the most studied. This adhesion is rapid (113), requires
divalent cations (113, 115), is temperature dependent (114),
and is inhibited by cytochalasin B (168). Fibronectin from one
species functions in vitro with cells from other species.
Fibronectin
The "cold-insoluble globulin" (CIg) ofblood, later identified
as a form of fibronectin (198) (Table IV), was originally
observed in 1948 in the precipitate that formed when blood
was allowed to clot in the cold (150, 228). Although they were
first thought to be part of the fibrinogen molecule (41), exam-
ination of the amino-acid sequences at the amino-termini of
these proteins showed them to be distinct (178). Cold-insoluble
globulin is a large molecule (440,000 daltons) with two similar
or identical chains linked by disulfide bonds (152). However,
the chains separate slightly on electrophoresis (27) and could
be modified forms of the same chain or different gene products.
The protein contains about 6% carbohydrate linked through
asparagine residues (25).
The presence of a protein closely related to CIg in connective
tissues and on the surface of cells was not discovered until
later. In 1973 and 1974, various studies indicated that one of
the most abundant glycoproteins on the surface of cells with
chains of 200,000 daltons disappeared after transformation
(59, 92, 98, 167, 191, 199, 229, 246). This glycoprotein has been
known by a variety ofsynonyms including cell surface protein
(CSP) (246) and "large, external, transformation-sensitive pro-
tein" (LETS) (99), but now is referred to as fibronectin (227).
The key role that a serum protein played in mediating the
adhesionoftrypsinized cells to collagen substrates was reported
independently by Hauschka and White (86) and also by Klebe
(113). Hauschka and White briefly reported that myoblasts
require a serum protein to bind to collagensubstrates, but those
authors made no further studies. Klebe, while studying the
attachment characteristics of established cells, found a serum
requirement for fibroblast attachment to collagen substrates
(113). Furthermore, he isolated the protein from serum, which
he named "collagen-dependent cell attachment protein" (c-
CAP). Subsequently, Pearlstein (164) demonstrated that CSP
had the ability to promote cell attachment to collagen.
Opsonic proteins that facilitate the phagocytic activities of
macrophages are known to be present in serum (3, 18, 94, 200,
241). These proteins, called anti-gelatin factor (241) and a2-
SB-glycoprotein (18), were isolated from serum and subse-
quently shown by independent studies to be identical to serum
fibronectin (38, 200). Fibronectin stimulates macrophages to
engulf particles coated with gelatin. It also binds DNA (248)
and actin (111), presumably also for opsonization.
The fibronectin in blood is not identical in all respects to
that in extracellular matrices and on cell surfaces. The blood
form is slightly smaller than the cell form (242). Furthermore,
after reduction two bands are observed when serum fibronectin
is electrophoresed in SDS, whereas a single diffuse band is
observed under similar conditions with the cell-associated fi-
bronectin. The serum form is fully soluble at neutral pH,
whereas the material extracted from the cells remains in solu-
tion best at pH 11. The blood and cellular forms are equally
active in mediating cell attachment at levels of 1-5 Fig/ml.
However, the cellular form is some 50 times more active inrestoring normal morphology to transformed cells (7, 242, 247).
The molecular basis for these differences has not been defined
but could arise from posttranslational modifications involving
TABLE III
Adhesion of Cells to Collagen
Cell type
* Numbers in parentheses are references.
$ Grotendorst, unpublished observations.
Preferred collagen
substrate
TABLE IV
Synonyms for Fibronectin
glycosylation reactions or proteolysis. Alternatively, the pro-
teins could be genetically distinct molecules.
Current studies indicate that fibronectin is a highly asym-
metric molecule in which the monomer has a Stokes radius of
110 El (245). Physical data suggest that fibronectin contains
several globular domains separated by more flexible segments
(5, 233). Different fragments ofthe molecule have been isolated
after protease treatment and found to have distinct binding
sites as shown schematically in Fig. 2. A fragment of 40,000
daltons near the amino-terminus contains the collagen-binding
site, whereas another fragment of -160,000 daltons binds to
the cell surface (11, 12, 57, 66, 83, 145, 196, 210). The 160,000-
dalton fragment does not bind to collagen but can promote cell
adhesion to plastic, whereas the collagen-binding fragment
(40,000 daltons) lacks cell-attachment activity (83, 84, 196).
One report describes a 50,000-dalton peptide from fibronectin
that can both bind to collagen and mediate cell adhesion (66).
Thus, although these two regions on the fibronectin molecule
are in distinct domains, they could be adjacent. Still another
portion of the molecule including the amino-terminal region
contains the site cross-linked by transglutaminase (156).
Fibronectin is quite antigenic and antibody to Fibronectin
has often been used to study its histological distribution (217,
234). Fibronectin is observed in the extracellular matrix around
many cells (20, 30, 88, 136, 226, 234) both in regular association
with collagen (20, 88, 226) and also as fibronectin filaments
lacking any association with collagen (30). Fibronectin is ob-
served on the surface of fibroblasts (197, 226, 246), astroglial
cells (229), endothelial cells (102), certain epithelial cells (29),
and myoblasts (55). The chondrocytes in cartilage lack the
protein but begin to synthesize it when placed in culture (39).
Role of Circulating Fibronectin in Wound Repair
The multiple interactions and biological activities ofplasma
fibronectin are consistent with it having a role in wound repair.
Fibronectin can bind and be cross-linked by transglutaminase
(155, 156) to itself (153, 232), fibrin (74, 198, 216), and collagen
(11, 12, 37, 46, 47, 66, 67, 78, 83, 84, 94, 103, 104, 106, 119, 120,
145, 164, 165, 196, 210, 242). It is likely that these interactions
are essential for the formation of the fibrin clot. As discussed
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Fibronectin-mediated
Established cells lines (CHO, 3T3, etc.)
(73, 122, 137, 168) I-IV
Primary fibroblasts (159) I-IV
Rat embryonic periosteum (123) I-IV
Rat hepatocytes (94) I-IV
Osteosarcoma (123) I-IV
Myoblasts (31, 112) I-IV
PMT (highly metastatic pulmonary tumor
cell) (158) 1-111
Embryonic sheep aortic smooth muscle
cells$ (67) I-III
Chondronectin-mediated
Chick sternal chondrocytes (89) II
Laminin-mediated
Breast epithelial cells (220) IV
Guinea pig epidermal cells (220) IV
EHS (basement membrane producing) tu-
mor cells (220) IV
TERA (transformed epidermal cells) (220) IV
PAM 212 (transformed epidermal cells)
(220) IV
PMT (highly metastatic pulmonary tumor
cell) (158, 220) IV
Human choroid epithelial cells (220) IV
PYS (parietal yolk sac cells) (220) IV
Monkey pigmented epithelial cells (220) IV
Sheep aorta vascular endothelial cells
(220) IV
Monkey lens epithelial cells (220) IV
Bovine lens epithelial cells (220) IV
Other adhesion mechanisms
Platelets (14, 204) Fibrillar Collagen
Embryonic sheep smooth muscle cells$ V
Name Property
Refer-
ences
Cold-insoluble globulin (Clg) Coprecipitates with cryofibrinogen 150
Surface fibroblast antigen (SFA), Present on the fibroblast cell surface and in serum and synthe- 197,199
renamed fibronectin sized by fibroblasts
Galactoprotein a (Gap a) Glycoprotein labeled with galactose oxidase-[3Hlborohydride 59
that is absent from transformed NIL cells
Large external transformation-sensitive Cell surface protein lost after in vitro transformation 98
protein (LETS)
Cell surface protein (CSP) High molecular weight cell protein on the surface of chick 246
embryo fibroblasts
L1 band Absent from transformed cells 92
Zeta proteins Absent from transformed chick embryo fibroblasts 191
Band 1 Absent from transformed BHK cells 167
Collagen-dependent cell attachment Serum glycoprotein that mediated cell adhesion to collagen 113
protein (c-CAP)
Anti-gelatin factor (AGF) Serum protein required by macrophages to ingest gelatin- 94,241
coated particles
a2-SB-opsonic glycoprotein Serum protein that promoted phagocytic activity 18
Cell spreading factor (SF) Serum fraction that promoted cell spreading 77O--S
COLLAGEN BINDING
REGION
SUGAR SUGAR
L
S-S
S-S
Milian
SUGAR
SUGAR SUGAR SUGAR
I--27K-i -40K F
￿
160K
￿
I
FIGURE 2
￿
Schematic model of the fibronectin molecule including
the location of specific domains. Peptides containing the collagen-
binding site (40K), the transglutaminase cross-linking site (27K), and
the cell-binding site (760K) are shown in their probable locations in
the molecule (11, 57, 154, 210) . Some or all of the sugars are in the
40,000-dalton region (154, 210) . The position of the S-S bonds is
from Wagner and Hynes (233) .
below, fibronectin appears to be involved in some platelet
reactions (10, 14, 204). As already mentioned, fibronectin has
opsoníc activity for macrophages (3, 18, 19, 94, 241), which
could be important for debriding the wound. Fibronectin may
also be one ofthe agents attracting fibroblasts into the wound,
because it is highly chemotactic forfibroblasts (61). In addition,
fibroblasts adhere to fibrin that has covalently bound fibronec-
tin (74). Once in the wound area, fibronectin could help
maintain the fibroblasts by promoting cell-matrix interactions
and stimulating matrix production (53).
Role of Fibronectin in Cell Attachment to
Collagen
Fibronectin promotes the attachment and subsequent
spreading of many cells (31, 73, 75, 77, 84, 93, 100, 113, 123,
137, 158, 164). In these studies, freshly dissociated cells are
incubated on a plastic or collagen substrate. Most cells will
synthesize their own attachment protein with time but, in short
incubations or when an inhibitor ofprotein synthesis is present,
the attachment ofmany trypsinized fibroblasts is stimulated by
serum and by fibronectin (76, 228). Under standard assay
conditions, 50% attachment of Chinese hamster ovary cells is
obtained with ^-40 ng/cm2 of fibronectin on a substrate con-
taining 100 ng/cm2 of collagen. The process is enhanced by
higher levels of fibronectin but is saturable. Three steps in the
process offibronectin-mediated attachment of cells to collagen
have been described (Fig. 3): (a) fibronectin binds to collagen,
(b) cells bind to Fibronectin-collagen complex, and (c) cell
spreading requires fibronectin and cellular metabolism.
Fibronectin will bind to a variety ofcollagen types including
types I-V (37, 46, 47, 103, 119, 123), but not to Ascaris collagen
(123) or to various synthetic peptides (119). The affinity of
fibronectin for denatured collagen is greater than for the native
protein. For example, Jilek and Hbrmann (103) found that
native type I collagen bound 1/100 ofthe amount ofFibronectin
bound by denatured type I collagen at 4°C. Type III collagen
was much more effective under these conditions, binding one-
fourth as well as denatured type I collagen to Fibronectin. It
should be noted that the binding of fibronectin to native
collagen occurred more slowly than to denatured collagen and
that equilibrium was not reached at this temperature. Greater
binding is found at physiological temperatures (106) and hep-
arin has been shown to enhance this binding (104, 106). The
fibrillar nature of the collagen is also an important factor in
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fibronectin binding, because the binding sites in the collagen
molecules in the internal portions of fibers would be unavail-
able for reaction. Fibrillar type III collagen binds fibronectin
more effectively than type I collagen does (47, 103), perhaps
because type III fibers are thinner (129).
The fibronectin binding site on type I collagen comprises an
unusual sequence of amino acids including the bond cleaved
by mammalian collagenase (37, 120). Cleavage of the al(I)
chain by mammalian collagenase, between residues 775-776,
is sufficient to destroy binding activity (120). A peptide of 35
amino-acid residues, which binds fibronectin and contains the
mammalian collagenase cleavage site (120), has been isolated
from the al(I)-chain. A smaller synthetic peptide including a
part of this region was also active (Fig. 4). The fibronectin-
binding site, like the rest ofthe helical domain, contains glycine
as every third residue, but lacks proline and hydroxyproline
and is hydrophobic. This region is less stable as a triple helix
than other segments ofcollagen (91). At physiological temper-
atures the helix may loosen, allowing fibronectin to bind.
Homologous peptides with binding activity have been isolated
from a2, a1(II), and al(III) (37, 117) (Fig. 5). Each sequence
contains the collagenase-sensitive bond, suggesting that the
binding of fibronectin occurs in the same region of each
collagen.
Various other components of the extracellular matrix may
also participate in cell adhesion. Fibronectin binds to proteo-
glycans (172, 243), and heparan sulfate is present in the adhe-
sion sites of cells (35). Fibronectin binds to both hyaluronic
acid and heparan sulfate (104, 213, 215, 243), and the interac-
tion of fibronectin with collagen appears to be stabilized by
both hyaluronic acid and heparan sulfate (195, 243). It is
possible that the relatively low binding ofFibronectin to native
collagen is attributable in part to the lack of an additional
factor, such as a proteoglycan that promotes their interaction
(104, 106).
Little is known about the nature of the cell surface compo-
nent that interacts with fibronectin. Certain complex ganglio-
sides with two or three sialic-acid residues have been shown to
bind to fibronectin (117) and inhibit cell adhesion but not alter
the binding offibronectin to collagen (118). The activity resides
in the carbohydrate portion ofthe glycolipid. Because ganglio-
sides are cell surface molecules, it is possible that they or other
glycoconjugates with a similar heteropolysaccharide are the
cell surface receptors for fibronectin. A possible model for the
interaction of fibronectin in an attachment site is depicted in
Fig. 6.
The interaction between the cell surface and the fibronectin-
collagen complex is being investigated by isolating and char-
acterizing cell mutants that are defective in adhesion. Poorly
adherent variants of Chinese hamster ovary cells have been
COLLAGEN
FIGURE 3
￿
Schematic model of fibronectin-mediated cell adhesion
to collagen in vitro. Fibronectin first binds to a specific sequence of
amino acids on the collagen chain (113, 120, 165). Then the cells in
the presence of Ca" or Mg" bind to the fibronectin-collagen
complex (115) and spread.COLLAGENASE
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FIGURE 4 Amino acid sequence of the collagen al(l)-chain known to bind fibronectin. The secondary structure of the active
region (residues 774-785) is diagramatically depicted as being more open than the remainder of the molecule whose tight helical
coil is depicted with regular curves. The fibronectin-binding site (residues 766-786) is shown in heavy letters.
isolated on the basis oftheir low adhesion to collagen (116). In
addition, the mutant cells adhered poorly to glass and tissue
culture plastic. Several adhesion-deficient cell strains have been
isolated by other selection procedures (169, 182). One mutant
has a defect in glycoprotein synthesis but reverts to a normal
phenotype in the presence ofadded N-acetylglucosamine (182).
A ricin-resistant fibroblast variant shows defective attachment
but synthesizes biologically active fibronectin (169). Analysis
of these mutants should help to clarify the interaction of the
fibronectin-collagen complex with the cell surface.
Cell-Substrate Adhesion Not Involving
Fibronectin
The attachment of baby hamster kidney (BHK) (78, 207)
and BALB 3T3 (137) cells to denatured collagen is stimulated
by added fibronectin, although some of these cells attach to
native collagen without added fibronectin. This has led to the
suggestion that different mechanisms are used to attach to the
native and denatured protein (137). Ifthis is so, it has not been
defined and more likely explanations have not been excluded.
For example, cells can utilize for attachment the fibronectin
they themselves produce (76). In this case, it would appear that
attachment to native collagen was more efficient with the newly
synthesized fibronectin. More studies are needed in this area.
Clearly, fibronectin is not involved in the attachment of all
cells (Table III). The matrix adjacent to epithelial cells and
chondrocyte usually lacks fibronectin (39, 217). These cells
abut on extracellular matrices that are quite distinct from
fibrous connective tissues. As discussed below, additional gly-
coproteins, apparently cell specific, attach chondrocytes (89)
and epithelial cells (159, 220) to their matrix.
Chondrocyte Attachment -Chondronectin
Cartilage does not contain fibronectin (39, 217), and purified
fibronectin does not promote the adherence of freshly isolated
chondrocytes, whereas fibronectin-free serum does (89). Chon-
dronectin, the chondrocyte-attachment factor in serum, can be
separated from fibronectin by DEAE-cellulose column chro-
matography. This protein is somewhat more heat-labile than
fibronectin (TL/2 =52'C vs. T1/2 =57*C) (Table V). As isolated
from serum, Chondronectin has a molecular weight of 180,000
daltons, and the molecule contains disulfide-linked chains (90).
Chondronectin is secreted by cultured chondrocytes and can
also be extracted from cartilage; it is presumed to be analogous
in function to fibronectin, but specific for chondrocytes. Inter-
estingly, once chondrocytes attach, fibronectin causes the cells
to flatten and appear fibroblastic and, at the same time, the
synthesis of cartilage-specific macromolecules is suppressed
(170, 237).
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FIGURE 5
￿
Activity of various cyanogen bromide-derived peptides
of collagen a-chains in binding fibronectin. The numbers between
the vertical lines indicate the cyanogen bromide peptide number.
The major peptides active in binding fibronectin are shaded (m).
Data on a2(I), al (I), a1(Il) are from Dessau et al. (37). Data on al(I)
and al(II) are from Kleinman et al. (119) . Data on al(III) are from
Kleinman and McGoodwin (unpublished observations).
FIGURE 6 Schematic model of an adhesion site. Collagen fibers
contain specific sites to which the fibronectin molecule binds. The
fibronectin molecule contains a region that recognizes collagen and
another region that recognizes the cell surface. The cell surface
receptor is thought to be aglycoconjugate, possibly a glycolipid that
interacts with cytoskeletal elements in some as yet unknown man-
ner. Proteoglycans are also present and stabilize the interaction. The
components of this model are not necessarily to scale.
Epithelial Cell Attachment -Laminin
Epithelial cells attach preferentially to type IV (basement
membrane) collagen and do not attach well to plastic or to
dishes coated with collagen types I, II, or III. The attachment
of epidermal cells (159), lens epithelial cells (97), and breast
epithelial cells (238) is slow and is not stimulated by serum or
fibronectin. Laminin, an 800,000-dalton glycoprotein found in
basement membranes (42, 52, 54, 132, 221), has been shown to
be the attachment factor for these cells (220) (Tables III and
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V). In the presence of laminin (1-5 ug/ml), epithelial cells
attach rapidly to type IV collagen. Laminin acts apparently in
a manner analogous to that of fibronectin in that it fast binds
to the substrate, type IV collagen, and then the cells bind to
the laminin-type IV collagen complex. Certain cells, such as
regenerating liver cells' and metastatic cells from the T241
fibrosarcoma (158), attach via fibronectin to a type I collagen
substrate and via laminin to a type IV collagen substrate.
Because some cells are capable of synthesizing both proteins
(53), it can be assumed that these cells utilize both mechanisms
for adhesion. In the case of the metastatic cells, the ability to
bind to different matrices may be important in their invasive
behavior.
The cells in the blood are largely nonadherent. However, in
culture, monocytes and neutrophils adhere to all collagen types
and to bacteriological plastic (122). It has been suggested that
fibronectin is the collagen receptor on the platelet cell surface
(14). Platelets contain fibronectin (14, 152, 176), which is
released during their aggregation by collagen or by thrombin
(249); however, only small amounts are found on the cell
surface (65). Antibody against fibronectin, however, only
blocks adhesion by 20% and has no effect on aggregation (204).
Furthermore, whereas fibronectin binds best to denatured col-
lagen (37, 46, 47, 103, 119), platelets are aggregated by native
and not by denatured collagen (60, 240). These observations
suggest that fibronectin does not participate in the initial step
in the platelet-collagen interaction. Once platelets adhere to
collagen, exogenous fibronectin enhances their flattening (75,
100). Recent evidence of a role for fibronectin in platelet
aggregation is suggested by studies on a patient with the Ehlers-
Danlos syndrome with poor wound healing and abnormal
platelet aggregation (10). This patient was found to have
normal levels of fibronectin, using an immunological assay.
However, only a slight aggregation of the patient's platelets
occurred in plasma while the addition of fibronectin from a
control subject corrected the defect. These data suggested that
the fibronectin from the patient was not functional in platelet
aggregation. Clearly, fibronectin is present in platelets and
involved in platelet function, but its role as the collagen recep-
tor is unlikely.
It is well established that normal cells must attach to a substrate
in culture to survive and divide (211). Such cells deposit
' Carlsson, R., E. Engvall, Y. Yoshida, A. Freeman, and E. Ruoslahu.
Laminin and fibronectin in cell adhesion. Enhanced adhesion ofcells
from regenerating liver. Manuscript in preparation.
480
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 88, 1981
TABLE V
Characteristics of Adhesion Factors
material on the surface ofthe dish as they adhere (34, 35, 133,
208). Under appropriate conditions, collagenous protein is
identified in the substrate attachment matrix (34, 208). As
expected, little collagenous protein is present when ascorbic
acid levels in the medium are low (30), because ascorbic acid
is necessary for maximal synthesis. Similarly, little collagen is
present when transformed cells are used, because they make
less collagen than normal cells (2, 71, 107, 135) or fail to
convert procollagen to collagen (9). It is likely that the plastic
or glass surface is adequate without collagen. Although it is
not clear how glass and plastic surfaces interact with the cell
membrane, more recent studies suggest that tissue culture
plastic adsorbs fibronectin and other glycoproteins that the
cells use for attachment (31, 73, 76, 77, 93). In this case, the
plastic and glass would serve as a surrogate for the natural
collagenous matrix.
Collagenous matrices, however, do alter the growth of nor-
mal and transformed cells in culture. Cells such as hepatocytes
(205), corneal endothelial cells (69), breast epithelial cells (238),
and epidermal cells (159) are maintained in a viable state
longer on a collagenous substrate than on plastic. Similarly, a
collagen substrate was found to prolong the lifespan ofcultured
chick fibroblasts (64). Growth-promoting effects have been
noted in culture with ascorbic acid (193) and attributed to the
ability of ascorbic acid to increase the production of a collag-
enous matrix (173). Dexamethasone (56) as well as butyrate
(87) induce normalization of the morphology in transformed
cells along with increasing the deposition of collagen (56) and
fibronectin (56, 87) by the cell. Possibly the reduced adhesive-
ness oftransformed cells and their failure to assume a normal
parallel alignment could be attributed to the reduced produc-
tion ofmatrix proteins.
Proline analogues that prevent the deposition of collagen
have been used to determine the necessity for collagen synthesis
during cell culture. Fibroblasts cultured in the presence of cis-
hydroxyproline begin to round up within a few hours and
eventually detach (108). However, cis-hydroxyproline has no
effect on growth (139) when cells are plated on a collagen
substratum (as low as 0.1 lag/cm) . This indicates that the cis-
hydroxyproline is not toxic to the cells but prevents the cells
from producing a collagenous matrix required for growth.
Using this analogue, it has been possible to determine the
requirement that certain cells have for specific collagens. Breast
epithelial cells will not grow on type I collagen in the presence
of cis-hydroxyproline but will grow on type IV collagen (238).
Thus, these cells specifically require a type IV collagen sub-
strate for growth.
Cis-hydroxyproline inhibits the growth of chick embryo
tendon fibroblasts in primary culture (108) and a variety of
other cells, but does not affect the growth of several trans-
Fibronectin Chondronectin Laminin
Molecular weight 450,000 180,000 800,000
Reduction Reduction 1 Reduction
220,000 80,000 200,000, 400,000
Activity in attachment 1-5 J~g 5-50 ng 1-5 Ag
Serum amount 200 ug/ml Below 20,ug/ml Below 1 tag/ml
Tissue location Fibrous connective tissue, some basement Cartilage, vitreous body Basement membrane
membranes
Heparin binding Yes Yes Yes
Heat lability 57°C 52°C 49°Cformed cell lines including KB cells, neuroblastoma cells, and
other cells listed in Fig. 7. These data (Fig. 7) suggest that the
tumorigenic cells that make only small amounts of collagen are
not dependent on collagen for growth.
MATRIX PROTEINS AND CELL DIFFERENTIATION
Possible roles for collagen in differentiation have been assessed
by growing cells on collagen substrates, by treating cells or
tissues with bacterial collagenase, and by treating cells with
drugs that interfere with collagen synthesis (Table VI).
Purified collagen substrates and collagenous matrices have
been shown to maintain differentiated functions as well as to
induce differentiation in cultured cells. One of the best-docu-
mented roles for collagen in differentiation is in the fusion of
myoblasts into multinucleated myoubes (85, 124). Myoblasts
are unable to form myotubes when plated in the absence of
fibroblasts (125). However, in the presence of conditioned
medium (124) or on collagen-coated dishes (85), they form
myotubes. Both native and denatured collagen support differ-
entiation, but only when the collagen is used as a substrate and
not when it is added to the medium (86). All mammalian
collagens tested are equally active in promoting muscle differ-
entiation (112), and it was found that the al(I)-CB7 peptide,
the fibronectin-binding peptide (37, 119), contains the active
region (86). A serum factor was shown to be necessary for the
attachment of myoblasts to collagen (86), and this was subse-
quently shown to be fibronectin (31). It is interesting to note
that as myoblasts fuse they lose their cell surface fibronectin
(28, 55), and the addition of exogenous fibronectin delays
fusion (177). Thus, myoblasts appear to require fibronectin for
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FIGURE 7
￿
Effect of cis-hydroxyproline on the growth of normal and
tumorigenic cells. Several normal (1, 3T3; 2, W138; and 3, early and
4, late passage adult connective tissue cells), and tumorigenic cells
(5, spontaneously transformed mouse connective tissue cells; 6, cells
derived from the tumor produced by injection of the transformed
mouse connective tissue cells; 7, cells from tumor derived from skin
of mice painted with methylcholanthrene; 8, cells derived from the
tumor arising as a result of subcutaneous injection of methylcholan-
threne; 9, SV-3T3 cells; and 10, cells from a metastatic fibrosarcoma
of the T241 fibrosarcoma) were tested for their ability to grow in the
presence of 25 pg/ml cis-hydroxyproline for 5 d. ", Tumorigenic;
O, nontumorigenic. Values are expressed as the percentage of cells
remaining after treatment. Data are from reference 230, with per-
mission.
attachment, whereas loss of fibronectin from the cell surface is
necessary for differentiation.
The differentiation of a variety ofother cell types is enhanced
by collagen, including somite chondrogenesis (126, 130), the
induction of matrix formation by corneal epithelium (146), and
the adhesion and development of some epidermal cells (159).
Somite chondrogenesis is improved by type I procollagen and
collagen, and type II collagen is even more effective (126, 130).
It is possible that the type II collagen synthesized by the
notochord induces chondrogenesis in somites in vivo. The
production of the epithelial stroma of the cornea is enhanced
by all collagens (40). Epidermal cells in culture often require
feeder layers of mesenchymal cells (189) or the presence of
collagen gels for growth (109). Type IV (basement membrane)
collagen has been found to promote the attachment and the
subsequent differentiation of epidermal cells into squamous
epithelium (159).
One of the most impressive activities ofa collagenous matrix
is the induction of bone by devitalized and decalcified bone
powder implanted in syngeneic hosts (186). This material
induces an outgrowth of mesenchyme cells that differentiate
into chondrocytes. Subsequently, blood vessels enter the area,
and the cartilage is replaced by osteoblasts. Later, osteoblasts
and marrow spaces containing hematopoietic cells form (186).
The cells at each stage synthesize unique matrix proteins (187),
and it is the matrix produced by the osteoblasts rather than the
implanted bone powder that mineralizes. In culture, the bone
powder also induces chondrocytes to develop from cells in
minced muscle tissue (160). It is not clear how the bone powder,
which is mostly collagen, acts. However, it has been suggested
that the collagenous matrix contains a firmly attached "in-
ducer" molecule (160).
Further evidence that collagen participates in differentiation
has been obtained by use of bacterial collagenase or drugs that
block collagen biosynthesis. Treatment with collagenase pre-
vents the development of feathers (218), lung (236), and sali-
vary epithelium (79) as well as the induction of notochord
cartilage by spinal cord (162). It is possible that noncollagenous
macromolecules are also involved, because the collagenases
used may have contained other enzymes including proteases.
Further, proteoglycans have been implicated as necessary for
salivary epithelial morphogenesis (17). Several drugs that in-
hibit collagen formation, including proline analogues, have
been shown to prevent lung morphogenesis (4, 214), salivary
gland formation (214), and ameloblast differentiation (194).
Collagen is not the only matrix protein known to influence
cell differentiation. For example, the phenotype of chondro-
cytes is altered by fibronectin. Although cartilage does not
contain fibronectin, freshly isolated chondrocytes, when cul-
tured at low cell density in the presence of serum, become
flattened, synthesize fibronectin, and retain it on their cell
surface (39). These effects are observed in cells grown on plastic
substrates but, as expected, occur more rapidly in cells grown
on collagen substrates (170). As cell density increases, chon-
drocytes become less flattened, synthesize increased amounts
of proteoglycan, and no longer retain fibronectin on their cell
surfaces. Chondrocytes grown in medium with serum depleted
of fibronectin are less flattened, produce more proteoglycan,
and synthesize and retain less fibronectin than cells grown with
fibronectin (170, 237). The "dedifferentiation" ofchondrocytes
observed in long-term culture (206) could be attributed in part
to the alterations in synthetic activities resulting from fibronec-
tin-dependent changes in cell shape.
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481Effect of pure Collagen substrates
Chick embryonic myoblast (124)*
Corneal epithelium (40)
Chick embryonic somites (126, 130)
Epidermal cells (159)
System
Effect of collagenaus matrices
Subcutaneous implant of decalcified bone
(186)
Muscle mesenchymal cells (160)
Neural crest mesenchymal cells (161)
Effect of enzymes or drugs
Chick embryonic skin tracts (218)
Embryonic salivary rudiment epithelium
(79, 214)
Chick embryonic lung epithelium, chick or
mouse embryonic ureteric bud (236)
Embryonic lung or tooth mesenchyme (4,
214)
Effect of fibronectin
Chick sternal chondrocytes (170, 237)
* Numbers in parentheses are references.
CONCLUSIONS
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TABLE VI
Role of Matrix Proteins in Cell Differentiation
Differentiated product
Multinucleated myotube cells
Production of stroma
Cartilage formation
Multilayered squamous epithelium
Bone formation
Cartilage and bone
Cartilage formation
Feather morphogenesis
Branched salivary glands
Cartilage formation
At present there are five well-identified isotypes of collagen
that vary in composition, fiberstructure, andtissue distribution,
suggesting that they play more than just a structural role. The
collagen isotypes are known to have somewhat different com-
positions depending on the type or age of the tissue. Because
collagens can interact with various attachment proteins and
proteoglycans, it is likely that unique andcomplex matrices are
formed that maintain the cells within thetissue anddirect their
growth and differentiation. Some examples of the affinity of
cells for the different collagen isotypes are known, including
chondrocytes that prefer type II collagen, and epidermal cells
and breast epithelial cellsthat prefer type IV collagen.
Although we regard most cells as permanent residents of the
tissues to which they belong because of their attachments to
othercells andto the extracellularmatrix, avariety of evidence
suggests that tumorigenic andparticularly metastatic cellsbe-
have differently. Many ofthe properties of these cellsrelate to
their reduced adhesion to a matrix and reduced synthesis of
fibronectin and collagen. Many tumorigenic cells synthesize
less collagen and probably less fibronectin, but synthesize
larger amounts of proteasesincludingcollagenases.As aresult,
the cells are less flattened in culture and less dependent on an
extracellular matrix for growth. Such factors would also in-
crease their invasiveness.
We wouldlike to thankDrs. J.M. Davidson, A. H. Reddi, M. E. Sobel,
J. Vuust, and K. M. Yamada for their critical reviews of this manu-
script.
Branched epithelium and maintenance
of shape of ureteric bud
Lung morphogenesis or ameloblast
differentiation
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